Literature DB >> 29998038

Prediction of off-target activities for the end-to-end design of CRISPR guide RNAs.

Jennifer Listgarten1, Michael Weinstein2,3, Benjamin P Kleinstiver4,5,6, Alexander A Sousa4,5, J Keith Joung4,5,6, Jake Crawford7, Kevin Gao7, Luong Hoang7, Melih Elibol7, John G Doench8, Nicolo Fusi9.   

Abstract

The CRISPR-Cas9 system provides unprecedented genome editing capabilities. However, off-target effects lead to sub-optimal usage and additionally are a bottleneck in the development of therapeutic uses. Herein, we introduce the first machine learning-based approach to off-target prediction, yielding a state-of-the-art model for CRISPR-Cas9 that outperforms all other guide design services. Our approach, Elevation, consists of two interdependent machine learning models-one for scoring individual guide-target pairs, and another which aggregates these guide-target scores into a single, overall summary guide score. Through systematic investigation, we demonstrate that Elevation performs substantially better than competing approaches on both tasks. Additionally, we are the first to systematically evaluate approaches on the guide summary score problem; we show that the most widely-used method performs no better than random at times, whereas Elevation consistently outperformed it, sometimes by an order of magnitude. We also introduce an evaluation method that balances errors between active and inactive guides, thereby encapsulating a range of practical use cases; Elevation is consistently superior to other methods across the entire range. Finally, because of the large scale and computational demands of off-target prediction, we have developed a cloud-based service for quick retrieval. This service provides end-to-end guide design by also incorporating our previously reported on-target model, Azimuth. (https://crispr.ml:please treat this web site as confidential until publication).

Entities:  

Year:  2018        PMID: 29998038      PMCID: PMC6037314          DOI: 10.1038/s41551-017-0178-6

Source DB:  PubMed          Journal:  Nat Biomed Eng        ISSN: 2157-846X            Impact factor:   25.671


  39 in total

1.  Cas9-chromatin binding information enables more accurate CRISPR off-target prediction.

Authors:  Ritambhara Singh; Cem Kuscu; Aaron Quinlan; Yanjun Qi; Mazhar Adli
Journal:  Nucleic Acids Res       Date:  2015-06-01       Impact factor: 16.971

2.  Genetic screens in human cells using the CRISPR-Cas9 system.

Authors:  Tim Wang; Jenny J Wei; David M Sabatini; Eric S Lander
Journal:  Science       Date:  2013-12-12       Impact factor: 47.728

3.  Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting.

Authors:  Andrew J Aguirre; Robin M Meyers; Barbara A Weir; Francisca Vazquez; Cheng-Zhong Zhang; Uri Ben-David; April Cook; Gavin Ha; William F Harrington; Mihir B Doshi; Maria Kost-Alimova; Stanley Gill; Han Xu; Levi D Ali; Guozhi Jiang; Sasha Pantel; Yenarae Lee; Amy Goodale; Andrew D Cherniack; Coyin Oh; Gregory Kryukov; Glenn S Cowley; Levi A Garraway; Kimberly Stegmaier; Charles W Roberts; Todd R Golub; Matthew Meyerson; David E Root; Aviad Tsherniak; William C Hahn
Journal:  Cancer Discov       Date:  2016-06-03       Impact factor: 39.397

4.  GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases.

Authors:  Shengdar Q Tsai; Zongli Zheng; Nhu T Nguyen; Matthew Liebers; Ved V Topkar; Vishal Thapar; Nicolas Wyvekens; Cyd Khayter; A John Iafrate; Long P Le; Martin J Aryee; J Keith Joung
Journal:  Nat Biotechnol       Date:  2014-12-16       Impact factor: 54.908

5.  CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets.

Authors:  Shengdar Q Tsai; Nhu T Nguyen; Jose Malagon-Lopez; Ved V Topkar; Martin J Aryee; J Keith Joung
Journal:  Nat Methods       Date:  2017-05-01       Impact factor: 28.547

6.  Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing.

Authors:  Nicola Crosetto; Abhishek Mitra; Maria Joao Silva; Magda Bienko; Norbert Dojer; Qi Wang; Elif Karaca; Roberto Chiarle; Magdalena Skrzypczak; Krzysztof Ginalski; Philippe Pasero; Maga Rowicka; Ivan Dikic
Journal:  Nat Methods       Date:  2013-03-17       Impact factor: 28.547

7.  CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences.

Authors:  Yanni Lin; Thomas J Cradick; Matthew T Brown; Harshavardhan Deshmukh; Piyush Ranjan; Neha Sarode; Brian M Wile; Paula M Vertino; Frank J Stewart; Gang Bao
Journal:  Nucleic Acids Res       Date:  2014-05-16       Impact factor: 16.971

8.  Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases.

Authors:  Richard L Frock; Jiazhi Hu; Robin M Meyers; Yu-Jui Ho; Erina Kii; Frederick W Alt
Journal:  Nat Biotechnol       Date:  2014-12-15       Impact factor: 54.908

9.  COSMID: A Web-based Tool for Identifying and Validating CRISPR/Cas Off-target Sites.

Authors:  Thomas J Cradick; Peng Qiu; Ciaran M Lee; Eli J Fine; Gang Bao
Journal:  Mol Ther Nucleic Acids       Date:  2014-12-02       Impact factor: 10.183

10.  CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering.

Authors:  Kornel Labun; Tessa G Montague; James A Gagnon; Summer B Thyme; Eivind Valen
Journal:  Nucleic Acids Res       Date:  2016-05-16       Impact factor: 16.971

View more
  64 in total

1.  Unified energetics analysis unravels SpCas9 cleavage activity for optimal gRNA design.

Authors:  Dong Zhang; Travis Hurst; Dongsheng Duan; Shi-Jie Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-15       Impact factor: 11.205

2.  CRISPR, animals, and FDA oversight: Building a path to success.

Authors:  Laura R Epstein; Stella S Lee; Mayumi F Miller; Heather A Lombardi
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-30       Impact factor: 11.205

Review 3.  Design and analysis of CRISPR-Cas experiments.

Authors:  Ruth E Hanna; John G Doench
Journal:  Nat Biotechnol       Date:  2020-04-13       Impact factor: 54.908

4.  Massively parallel kinetic profiling of natural and engineered CRISPR nucleases.

Authors:  Stephen K Jones; John A Hawkins; Nicole V Johnson; Cheulhee Jung; Kuang Hu; James R Rybarski; Janice S Chen; Jennifer A Doudna; William H Press; Ilya J Finkelstein
Journal:  Nat Biotechnol       Date:  2020-09-07       Impact factor: 54.908

5.  Efficient CRISPR/Cas9-Mediated Mutagenesis in Primary Murine T Lymphocytes.

Authors:  Bonnie Huang; Kristoffer Haurum Johansen; Pamela L Schwartzberg
Journal:  Curr Protoc Immunol       Date:  2018-10-12

6.  CRISPRitz: rapid, high-throughput and variant-aware in silico off-target site identification for CRISPR genome editing.

Authors:  Samuele Cancellieri; Matthew C Canver; Nicola Bombieri; Rosalba Giugno; Luca Pinello
Journal:  Bioinformatics       Date:  2020-04-01       Impact factor: 6.937

7.  Plant Genome Editing and the Relevance of Off-Target Changes.

Authors:  Nathaniel Graham; Gunvant B Patil; David M Bubeck; Raymond C Dobert; Kevin C Glenn; Annie T Gutsche; Sandeep Kumar; John A Lindbo; Luis Maas; Gregory D May; Miguel E Vega-Sanchez; Robert M Stupar; Peter L Morrell
Journal:  Plant Physiol       Date:  2020-05-26       Impact factor: 8.340

8.  Optimizing CRISPR/Cas9 technology for precise correction of the Fgfr3-G374R mutation in achondroplasia in mice.

Authors:  Kai Miao; Xin Zhang; Sek Man Su; Jianming Zeng; Zebin Huang; Un In Chan; Xiaoling Xu; Chu-Xia Deng
Journal:  J Biol Chem       Date:  2018-11-28       Impact factor: 5.157

9.  Genetic interaction mapping and exon-resolution functional genomics with a hybrid Cas9-Cas12a platform.

Authors:  Thomas Gonatopoulos-Pournatzis; Michael Aregger; Kevin R Brown; Shaghayegh Farhangmehr; Ulrich Braunschweig; Henry N Ward; Kevin C H Ha; Alexander Weiss; Maximilian Billmann; Tanja Durbic; Chad L Myers; Benjamin J Blencowe; Jason Moffat
Journal:  Nat Biotechnol       Date:  2020-03-16       Impact factor: 54.908

10.  crisprSQL: a novel database platform for CRISPR/Cas off-target cleavage assays.

Authors:  Florian Störtz; Peter Minary
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.